Reduced T-cell Numbers and Elevated Levels of Immunomodulatory Cytokines in Metastatic Prostate Cancer Patients De Novo Resistant to Abiraterone and/or Enzalutamide Therapy. [electronic resource]
Producer: 20190809ISSN:- 1422-0067
- Aged
- Aged, 80 and over
- Androgen Antagonists -- therapeutic use
- Androstenes -- pharmacology
- Benzamides
- Biomarkers, Tumor
- Cell Line, Tumor
- Cytokines -- blood
- Drug Resistance, Neoplasm
- Humans
- Immunomodulation -- drug effects
- Lymphocyte Count
- Male
- Middle Aged
- Myeloid-Derived Suppressor Cells -- immunology
- Nitriles
- Phenylthiohydantoin -- analogs & derivatives
- Prostatic Neoplasms -- drug therapy
- T-Lymphocytes -- immunology
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.